GS
79
3
PH
67
-3
AIG
56
2
MS
72
3
SIG
72
2
TSCO
50
-6
UAL
54
-10
ALLE
48
7
EMC
74
20
JBHT
38
12
HSY
53
2
LOW
56
3
LEG
11
-5
AMZN
64
5
JWN
67
7
AAL
39
3
A
44
-2
C
46
2
OMC
65
7
NTAP
67
8
GS
79
3
PH
67
-3
AIG
56
2
MS
72
3
SIG
72
2
TSCO
50
-6
UAL
54
-10
ALLE
48
7
EMC
74
20
JBHT
38
12
HSY
53
2
LOW
56
3
LEG
11
-5
AMZN
64
5
JWN
67
7
AAL
39
3
A
44
-2
C
46
2
OMC
65
7
NTAP
67
8
Financhill
Back

Novo Nordisk A/S Quote, Financials, Valuation and Earnings

DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon

Discover our top DeFi pick for potentially massive gains now (before it's too late).
Buy
56

NVO
Novo Nordisk A/S

Last Price:
123.06
Seasonality Move:
5.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!

Novo Nordisk A/S Price Quote

$123.06
-0.96 (-0.77%)
(Updated: May 3, 2024 at 6:55 PM ET)

Novo Nordisk A/S Key Stats

Buy
56
Novo Nordisk A/S (NVO) is a Buy
Day range:
$123.83 - $127.94
52-week range:
$75.56 - $138.28
Dividend yield:
1.11%
P/E ratio:
45.88
P/S ratio:
15.65
P/B ratio:
38.67%
Volume:
8.3M
Avg. volume:
3.9M
1-year change:
48.35%
Market cap:
$553.3B
Revenue:
$33.7B
EPS:
$2.9

How Much Does Novo Nordisk A/S Make?

Is Novo Nordisk A/S Growing As A Company?

  • What Is Novo Nordisk A/S's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.24%
  • What Is Novo Nordisk A/S's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.31%

Novo Nordisk A/S Stock Price Performance

  • Did Novo Nordisk A/S Stock Go Up Last Month?
    Novo Nordisk A/S share price went down by -1.93% last month
  • Did NVO's Share Price Rise Over The Last Year?
    NVO share price rose by 48.35% over the past 1 year

What Is Novo Nordisk A/S 52-Week High & Low?

Novo Nordisk A/S Price To Free Cash Flow

Is It Risky To Buy Novo Nordisk A/S?

  • How Much Debt Does Novo Nordisk A/S Have?
    Total long term debt quarterly is $3.9B
  • How Much Cash Does Novo Nordisk A/S Have?
    Cash and short term investments quarterly total is $1.3B
  • What Is Novo Nordisk A/S’s Book Value Per Share?
    Book value per share is 3.21

Is Novo Nordisk A/S Cash Flow Positive?

  • What Is NVO Cash Flow From Operations?
    Cash flow from operations (TTM) is $13.6B
  • What Is Novo Nordisk A/S’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$10B
  • What Is Novo Nordisk A/S’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.8B

Novo Nordisk A/S Return On Invested Capital

  • Is Management Doing A Good Job?
    NVO return on invested capital is 75.11%
  • What Is Novo Nordisk A/S Return On Assets?
    ROA measures how assets are converting to revenues and is 30.93%
  • What Is NVO Return On Equity?
    ROE is a measure of profitability and is 95.26%

Novo Nordisk A/S Earnings Date & Stock Price

Novo Nordisk A/S Competitors

  • Who Are Novo Nordisk A/S's Competitors?
    Below is a list of companies who compete with Novo Nordisk A/S or are related in some way:
    • Amgen Inc (AMGN)
    • AstraZeneca PLC (AZN)
    • Evaxion Biotech AS (EVAX)
    • Viking Therapeutics Inc (VKTX)
    • Vertex Pharmaceuticals Inc (VRTX)

Novo Nordisk A/S Dividend Yield

Novo Nordisk A/S Analyst Estimates

YoY Growth Past Surprise
EPS: 30.68% 0%
Revenue: 23.68% 2.47%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 1
Price Target: 136.71
Upside from Last Price: 10.24%

Major Shareholders

  • How many NVO shares are owned by institutional investors?
    399.1M NVO shares are owned by institutional investors
  • How many NVO shares are owned by insiders?
    0 NVO shares are owned by insiders